The OncoAlert Newsletter
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
In an open-label, randomized, phase 3 trial, we compared the efficacy and safety of paclitaxel with that of paclitaxel plus bevacizumab, a monoclonal antibody against…
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the…
A new study by Sylvester researchers used trends in tracheal, bronchial and lung cancer deaths to emphasize the need for policy vigilance.
Lung and related cancer deaths decreased in the world’s 10 most populous countries over the past 40 years, but there is still a pressing need…
Key PointsAdding navitoclax to ongoing ruxolitinib demonstrates durable responses and potential disease modification in relapsed/refractory MF.Thrombocytop
Not satisfied with what he’s done to America, the world’s richest man is now looking to interfere in a European country.
Massive wind-driven fires in Los Angeles County have killed at least five people and left others with “significant injuries.” Follow for live updates.
AbstractBackgroundAircraft noise is a growing concern for communities living near airports.ObjectivesThis study aimed to explore the impact of aircraft noise on heart structure and function.Methods…
Immunotherapies, specifically monoclonal antibodies targeting the programmed death–1 and programmed death-ligand 1 axis, have rapidly become integral in the management of most patients with early-stage…
The OncoAlert Newsletter is now out for June 23-29, 2023